TrialClinical pharmacology in drug development2025
Population Pharmacokinetic and Exposure-Response Analysis of the Cognitive Effects of TAK-071 in Participants With Parkinson Disease and Cognitive Impairment.
Hongxia Jia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.